Dr. Christopher Pieczonka, MD
Claim this profileAssociated Medical Professionals of NY
Studies Prostate Cancer
Studies Bladder Cancer
11 reported clinical trials
22 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
2Bladder Cancer
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Christopher Pieczonka, MD is currently running
Pemigatinib
for Bladder Cancer
This trial tests how well Pemigatinib, a pill that blocks proteins helping cancer grow, works in patients with bladder cancer that has come back after previous treatment. The drug aims to stop specific proteins needed for cancer growth.
Recruiting2 awards Phase 25 criteria
Hormone Therapy + Radiation
for Prostate Cancer
This research study is comparing the use of a new form of hormonal therapy used with radiation as a possible treatment for intermediate risk prostate cancer. More specifically, this research would help determine whether this new form of hormonal therapy is as effective as the standard hormone therapy while also preserving erectile function.
Recruiting1 award Phase 236 criteria
More about Christopher Pieczonka, MD
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Christopher Pieczonka, MD has experience with
- Tazemetostat
- Enzalutamide
- Abiraterone/prednisone
- Radium Dichloride
- Stereotactic Body Radiation Therapy
- PET Scan
Breakdown of trials Christopher Pieczonka, MD has run
Prostate Cancer
Bladder Cancer
Transitional Cell Carcinoma
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher Pieczonka, MD specialize in?
Christopher Pieczonka, MD focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Christopher Pieczonka, MD currently recruiting for clinical trials?
Yes, Christopher Pieczonka, MD is currently recruiting for 2 clinical trials in Syracuse New York. If you're interested in participating, you should apply.
Are there any treatments that Christopher Pieczonka, MD has studied deeply?
Yes, Christopher Pieczonka, MD has studied treatments such as Tazemetostat, Enzalutamide, Abiraterone/prednisone.
What is the best way to schedule an appointment with Christopher Pieczonka, MD?
Apply for one of the trials that Christopher Pieczonka, MD is conducting.
What is the office address of Christopher Pieczonka, MD?
The office of Christopher Pieczonka, MD is located at: Associated Medical Professionals of NY, Syracuse, New York 13210 United States. This is the address for their practice at the Associated Medical Professionals of NY.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.